Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 20,116 | 24,208 | 20,037 | 15,799 | 16,652 |
| Gross Profit | 20,116 | 24,208 | 20,037 | 15,799 | 16,652 |
| Operating Expenses | 122,264 | 123,136 | 109,022 | 107,102 | 98,618 |
| Operating Income | -102,148 | -98,928 | -88,985 | -91,303 | -81,966 |
| Other Income | 19,372 | 2,468 | 51,636 | -15,862 | 10,016 |
| Pre-tax Income | -82,776 | -96,460 | -37,349 | -107,165 | -71,950 |
| Income Tax | N/A | N/A | 1,000 | 2,410 | N/A |
| Net Income Continuous | -82,776 | -96,460 | -38,349 | -109,575 | -71,950 |
| Net Income | $-82,776 | $-96,460 | $-38,349 | $-109,575 | $-71,950 |
| EPS Basic Total Ops | -1.08 | -1.33 | -0.54 | -1.56 | -1.02 |
| EPS Basic Continuous Ops | -1.08 | -1.33 | -0.54 | -1.56 | -1.02 |
| EPS Diluted Total Ops | -1.08 | -1.33 | -0.54 | -1.56 | -1.02 |
| EPS Diluted Continuous Ops | -1.08 | -1.33 | -0.54 | -1.56 | -1.02 |
| EPS Diluted Before Non-Recurring Items | -1.08 | -1.33 | -0.54 | N/A | N/A |
| EBITDA(a) | $-104,905 | $-101,213 | $-90,143 | $-91,047 | $-79,249 |